Kate M. Fife

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Cemiplimab for Unresectable Cutaneous Squamous Cell Carcinoma: Experience From a Tertiary Center.

Cemiplimab for Unresectable Cutaneous Squamous Cell Carcinoma: Experience From a Tertiary Center.

Journal: Cutis
Published: July 24, 2026

Erratum to "Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review". [Cancer Treat. Rev. 140 (2025) 103024].

Erratum to "Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review". [Cancer Treat. Rev. 140 (2025) 103024].

Journal: Cancer treatment reviews
Published: March 04, 2026

Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case report.

Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case report.

Journal: BJC reports
Published: February 03, 2026

Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI.

Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI.

Journal: Abdominal radiology (New York)
Published: August 20, 2025

Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review.

Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review.

Journal: Cancer treatment reviews
Published: June 03, 2025

Recurrent vismodegib drug-induced liver injury with corticosteroid response.

Recurrent vismodegib drug-induced liver injury with corticosteroid response.

Journal: BMJ case reports
Published: April 03, 2025

'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.

'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.

Journal: BJU international
Published: July 17, 2024

Variability in Kidney Cancer Treatment and Survival in England: Results of a National Cohort Study.

Variability in Kidney Cancer Treatment and Survival in England: Results of a National Cohort Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 25, 2024

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2023

Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers.

Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 26, 2023

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).

Journal: British journal of cancer
Published: March 14, 2022

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 24, 2021
Showing 1-12 of 56

Last Updated: 09/26/2026